October 17, 2025

Maze Therapeutics, Inc. (MAZE) Investor Outlook: Strong Buy Ratings and Potential 32.98% Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company based in South San Francisco, California, is making waves in the biotechnology sector with its cutting-edge approach to precision medicine. Specializing..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Data Leader with 24.71% Upside Potential

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services industry, has captured investor attention with its potential upside of 24.71%, based on the average target price of..

Upstream Bio, Inc. (UPB) Investor Outlook: Unpacking the 123% Potential Upside in Biotech

Upstream Bio, Inc. (UPB), a promising player in the biotechnology sector, has caught the attention of investors with its impressive growth metrics and significant target price upside. Specializing in the..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 15.8% Upside Potential in the Cannabis Sector

Tilray Brands, Inc. (TLRY), a prominent player in the healthcare sector, is making waves in the specialty and generic drug manufacturing industry. Headquartered in Leamington, Canada, Tilray operates globally, engaging..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Landscape with a 44.82% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) operates within the healthcare sector, specifically focusing on medical care facilities. With a market cap of $420.99 million, this Boca Raton-based company specializes in..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A 200% Upside Potential in the Biotech Space

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is attracting significant attention from investors with its promising pipeline of innovative treatments for autoimmune diseases and cancer. Based in Cambridge,..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 72% Potential Upside Beckons Amid Biotech Innovation

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has captured the attention of investors with its pioneering work in the biotechnology sector. Specializing in developing complement therapeutics for severe autoimmune and inflammatory diseases,..

Talkspace, Inc. (TALK) Stock Analysis: A 64.95% Upside Potential Amidst Growing Healthcare Demand

Investors with an eye on the healthcare sector may find Talkspace, Inc. (NASDAQ: TALK) an intriguing prospect, particularly given its substantial potential upside of 64.95%, as indicated by recent analyst..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech Player with Remarkable Revenue Growth and Promising Drug Pipeline

Investors keen on the biotechnology sector may find Stoke Therapeutics, Inc. (NASDAQ: STOK) an intriguing company to watch. With its innovative approach to treating severe genetic diseases and a recent..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: A 281% Potential Upside on the Horizon

Anavex Life Sciences Corp. (NASDAQ: AVXL) is making waves in the biotechnology sector with its promising pipeline of treatments targeting a range of neurodegenerative and neuropsychiatric disorders. With a market..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A 38.76% Potential Upside in Cutting-Edge Gene Editing

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneering biotechnology firm specializing in gene editing, presents a compelling investment opportunity with a potential upside of 38.76%. As a leader in the healthcare..

RxSight, Inc. (RXST) Stock Analysis: Evaluating Growth Potential Amidst Market Challenges

RxSight, Inc. (NASDAQ: RXST), a pioneering name in the healthcare sector, specifically in medical devices, is drawing investor attention with its innovative approach to enhancing post-cataract surgery outcomes. Specializing in..

Inventiva S.A. (IVA) Stock Analysis: Unpacking a 227% Potential Upside in Biotech

Inventiva S.A. – American Depositary Shares (IVA) is a name that has been turning heads in the biotech sector. Trading on the healthcare-focused biotechnology industry, Inventiva offers a compelling opportunity..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 58% Potential Upside with Strong Buy Ratings

Castle Biosciences, Inc. (NASDAQ: CSTL), a burgeoning player in the healthcare sector, is making waves in the diagnostics and research industry, particularly with its innovative molecular diagnostic solutions. Headquartered in..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Can This Biotech Innovator Turn Challenges into Opportunities?

Fortrea Holdings Inc. (NASDAQ: FTRE), a nascent player in the healthcare sector, is navigating the complexities of its role as a contract research organization. With a market capitalization of approximately..

Zenas BioPharma, Inc. (ZBIO)

⚠️ No article content returned.

..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Exploring a Promising 105.95% Upside Potential

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a burgeoning player in the biotechnology sector, offers an intriguing opportunity for investors seeking exposure to the healthcare space. With a focus on developing and..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Biotech Gem with a 351.84% Potential Upside

Investors seeking opportunities in the biotechnology sector should keep a keen eye on Tectonic Therapeutic, Inc. (NASDAQ: TECX). With a market capitalization of $330.27 million, Tectonic Therapeutic is making waves..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth in Healthcare Diagnostics with a Potential 11% Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a name that continues to capture the attention of investors in the Healthcare sector, particularly within the Diagnostics & Research industry. Based in El..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Eyeing a 26% Upside with Precision Therapies in Focus

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotechnology sector with its focused approach on precision therapies for genetically defined diseases. As an investor, understanding the dynamics of..

Search

Funds

October 17, 2025

Search

Funds

October 17, 2025

FTSE 100

Funds